Anton Hoos
Direktor/Vorstandsmitglied bei Patient Focused Medicine Development
Profil
Anton Hoos is currently the Director at Patient Focused Medicine Development since 2014.
He was previously the Vice President at CSL Behring GmbH.
In 2023, he briefly served as the Chief Medical Officer, Head-Medical Affairs, R&D at Swedish Orphan Biovitrum AB.
Dr. Hoos holds an MBA from the University of Toronto and a doctorate from Ludwig-Maximilians-Universität München.
Aktive Positionen von Anton Hoos
| Unternehmen | Position | Beginn |
|---|---|---|
| Patient Focused Medicine Development | Direktor/Vorstandsmitglied | 01.01.2014 |
Ehemalige bekannte Positionen von Anton Hoos
| Unternehmen | Position | Ende |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Technik-/Wissenschafts-/F&E-Leiter | 19.06.2023 |
CSL Behring GmbH
 CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey. | Corporate Officer/Principal | - |
Ausbildung von Anton Hoos
| University of Toronto | Masters Business Admin |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey. | Health Technology |
| Patient Focused Medicine Development |
